Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ONYX PHARMACEUTICALS INC Financial Overview

  • Income Statement: ONXX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 194.34 M 90.43 M 103.91 M 53.47%
    Gross Profit 193.01 M 89.40 M 103.61 M 53.68%
    Net Income Before Extra Items/Preferred Div 1.95 M -34.17 M 36.12 M 1,853.95%
    Operating Income -10.40 M -53.42 M 43.02 M -413.68%
  • Cash Flow: ONXX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 2.58 M 226.70 M -224.12 M -8,673.26%
    Net Cash Flow - Investing -79.36 M 133.02 M -212.38 M 267.62%
    Net Cash Flow/Operating Activities -8.44 M -26.44 M 18.00 M -213.10%
  • Balance Sheet: ONXX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 509.77 M 484.08 M 25.68 M 5.04%
    Total Liabilities 34.57 M 51.85 M -17.28 M -49.99%
    Shareholders Equity 475.20 M 432.24 M 42.96 M 9.04%
  • Key Ratios / Statistics: ONXX

    • Valuation

      Price/Earnings (TTM) 1,138.67
      Price/Sales (TTM) 9.98
      Price/Book (MRQ) 2.49
      Price/Cash Flow (TTM) 103.76
    • Profitability

      Gross Margin 99.31
      Operating Margin -5.35
      Profit Margin 1.00
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 13.64
      Current Ratio (MRQ) 37.73
      Long Term Debt-to-Equity (MRQ) 18.91
    • Management Effectiveness

      Return on Equity (TTM) -10.58
      Return on Assets (TTM) -0.97
      Return on Investments (TTM) 0.43